In summary, MTX-HSA is a promising example of the importance of drug carriers in developing a new generation of targeted therapeutic drugs. Targeting inflamed joints by this MTX-HSA compound drug might be an attractive strategy in the treatrpent of chronic inflammatory rheumatic diseases such as RA. © British Society for Rheumatology 2004; all rights reserved.
CITATION STYLE
Elewaut, D. (2004, September). Right on target: Coupling methotrexate to albumin to treat rheumatoid arthritis. Rheumatology. https://doi.org/10.1093/rheumatology/keh242
Mendeley helps you to discover research relevant for your work.